Sanara MedTech
SMTI
24 hedge funds and large institutions have $13.1M invested in Sanara MedTech in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
34% more capital invested
Capital invested by funds: $9.72M → $13.1M (+$3.35M)
14% more funds holding
Funds holding: 21 → 24 (+3)
1.48% more ownership
Funds ownership: 3.53% → 5.01% (+1.5%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.45M |
| 2 |
NRC
North Run Capital
Boston,
Massachusetts
|
+$1.01M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
+$717K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$463K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$215K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$270K |
| 2 |
LCM
Laurion Capital Management
New York
|
-$200K |
| 3 |
SMG
Smart Money Group
Eastland,
Texas
|
-$157K |
| 4 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$134K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$94.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| – | -$143 | -4 | -40% |
|
SMTI Hedge Fund Activity: Q3 2021 in Review
24 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q3 2021, worth a combined $13.1M — up 34% from $9.72M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SMTI positions and 3 closed out — a net gain of 3 holders — while 6 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $2.45M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $270K sold.
- 24 institutional investors held Sanara MedTech (SMTI) as of Q3 2021, up from 21 in Q2 2021.
- Funds reported $13.1M of Sanara MedTech stock for Q3 2021, up 34% quarter-over-quarter.
- 6 funds opened new Sanara MedTech positions in Q3 2021 and 3 closed out, a net change of +3 holders.
- The largest Sanara MedTech buyer in Q3 2021 was Fidelity Investments, an estimated $2.45M added.
- The largest Sanara MedTech seller in Q3 2021 was Renaissance Technologies, an estimated $270K sold.
Based on aggregated 13F filings for Q3 2021.